GLP-1 Analog Use is Associated With Improved Disease Course in Inflammatory Bowel Disease: A Report from the Epi-IIRN - Summary - MDSpire

GLP-1 Analog Use is Associated With Improved Disease Course in Inflammatory Bowel Disease: A Report from the Epi-IIRN

  • By

  • Yuri Gorelik

  • Itai Ghersin

  • Rona Lujan

  • Dima Shlon

  • Yiska Loewenberg Weisband

  • Amir Ben-Tov

  • Eran Matz

  • Galia Zacay

  • Iris Dotan

  • Dan Turner

  • Haggai Bar-Yoseph

  • October 23, 2024

  • 0 min

Share

Objective:

To investigate the association between GLP-1 analog use and inflammatory bowel disease (IBD) outcomes in patients with type 2 diabetes mellitus (DM2), highlighting its clinical significance.

Key Findings:
  • GLP-1 analog use was associated with a reduced composite outcome in the full cohort (aHR 0.74, 95% CI 0.62-0.89), indicating a clinically significant reduction in poor outcomes.
Interpretation:

GLP-1 analogs may improve IBD outcomes, particularly in patients with obesity, suggesting a potential therapeutic role in managing IBD and warranting further exploration.

Limitations:
  • The study is observational and may be subject to confounding factors, such as variations in treatment adherence and comorbidities.
Conclusion:

GLP-1 analogs are associated with improved outcomes in IBD, especially in obese patients, warranting further investigation into their mechanisms and effects in non-DM2 patients, emphasizing the need for future research.

Original Source(s)

GLP-1 Analog Use is Associated With Improved Disease Course in Inflammatory Bowel Disease: A Report from the Epi-IIRN

  • by Yuri Gorelik, Itai Ghersin, Rona Lujan, Dima Shlon, Yiska Loewenberg Weisband, Amir Ben-Tov, Eran Matz, Galia Zacay, Iris Dotan, Dan Turner, Haggai Bar-Yoseph

  • October 23, 2024

Related Content

The Heresy of Hypoabsorptive Bariatric Surgery: A Critical Reappraisal of Long-Term Outcomes and Clinical Trade-Offs

Casein hydrolysate promotes intestinal repair in adult mice with Salmonella enteritis through a lactate-GPR81-Wnt3A axis in intestinal stem cell niche

Editorial: Community series in towards precision medicine for immune-mediated disorders: advances in using big data and artificial intelligence to understand heterogeneity in inflammatory responses, volume III